Key regions: Brazil, India, Australia, United States, United Kingdom
Antiviral drugs have been an essential part of the global healthcare industry for many years. These drugs are used to treat viral infections and are in high demand due to the ongoing COVID-19 pandemic. The Antiviral Drugs market in Zambia has been developing at a steady pace due to various factors.
Customer preferences: The Zambian population has shown a growing preference towards antiviral drugs due to the increasing prevalence of viral infections in the country. The demand for these drugs has also been driven up due to the COVID-19 pandemic. However, due to the high cost of these drugs, many Zambians still rely on traditional medicine to treat viral infections.
Trends in the market: The Antiviral Drugs market in Zambia has been growing at a steady pace due to the increasing prevalence of viral infections in the country. The COVID-19 pandemic has also contributed to the growth of the market as there has been a surge in demand for antiviral drugs. However, the market is still largely dominated by international pharmaceutical companies, and there is a need for more local companies to enter the market.
Local special circumstances: The Zambian government has been working towards improving the healthcare system in the country. The government has been investing in infrastructure and has also been working towards providing affordable healthcare to the population. However, there is still a need for more investment in the healthcare sector to improve access to antiviral drugs.
Underlying macroeconomic factors: The Zambian economy has been growing at a steady pace over the past few years, which has led to an increase in disposable income among the population. This has contributed to the growth of the Antiviral Drugs market in Zambia as more people are able to afford these drugs. However, the high cost of these drugs remains a barrier to access for many Zambians.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
